Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Gossamer Works Around The Shutdown To Price Its $230m IPO

26 Jan 2019

• By Mandy Jackson, Kevin Grogan, and Jo Shorthouse

Finance Watch

Related Content

Finance Watch: Not Everyone Can Go Public, But Biopharma IPOs Are Using Multiple Markets

15 Nov 2018

IPO Update: Returns Sag As Seven More Biopharmas Go Public In September

02 Oct 2018

Finance Watch: Rough US Stock Market Doesn't Stop Biopharma IPOs As Six More Go Public

31 Oct 2018

Pipeline Watch: Phase III Starts With STR001, Cabometyx And Brazikumab

15 Oct 2018

Takeda Catches Rising Tide Of Antisense Neuroscience R&D

21 Feb 2018

Finance Watch: A Plethora Of Big Rounds, Led By Gossamer's $230m Series B

31 Jul 2018

Deal Watch: Gilead Continues To Add To IO Armamentarium In Collaboration With Gadeta

20 Jul 2018

Finance Watch: VC Deals Keep Up Fast Pace With $1.1bn In Less Than Three Weeks

18 Jan 2019

UroGen's Lead Product Data Back Barrett's Interest

09 Jan 2019

Oncology Leader Liz Barrett Joins UroGen As CEO As It Heads Towards Commercial Stage

03 Jan 2019

IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year

04 Jan 2019

Finance Watch: Recent Offerings Show Some Companies Were Ready For The Government Shutdown

16 Jan 2019

Finance Watch: Dementia Discovery Fund Exceeds Fundraising Goal By $150m

26 Jun 2018

Celgene diversifies with $7.2bn Receptos buy

15 Jul 2015

Cirius Eyes Phase III Plans In NASH With Interim Data Showing Liver, Metabolic Benefits

26 Oct 2018

Related Companies

Gossamer Bio, Inc.

Receptos, Inc.

Bristol Myers Squibb Company

Marinomed Biotech AG

Alzheon Inc.

Kaleido Biosciences, Inc.

Cirius Therapeutics, Inc.

Alector, Inc.

Anchiano Therapeutics Ltd.

PTC Therapeutics, Inc.

Wave Life Sciences Ltd.

UroGen Pharma, Ltd.

Takeda Pharmaceutical Co. Ltd.

Novartis AG

Sunesis Pharmaceuticals, Inc.

Bellerophon Therapeutics Inc.

University of Cambridge

Lund University

Additional Topics

Financing Business Strategies Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.